Cannabis Law Report

NOVEMBER 17, 2021

This National Epilepsy Awareness Month, TXOG advocates for the power of medical cannabis for epilepsy patients. Diagnosed with epilepsy at 3 years old, Ortiz would experience erratic, unpredictable seizure clusters, each lasting 20 minutes. We remain committed to advancing safe, legal access to this powerful medicine.

Patients 52

Patients Epilepsy Medicine Advocacy 52

Canna Care Docs

DECEMBER 16, 2020

It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it. Enough is enough. What conditions is medical marijuana helpful for? Multiple sclerosis.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Veriheal

NOVEMBER 20, 2020

While Oregon became the first state to decriminalize all drugs , this election cycle also saw five other states passing legislation that will ultimately make cannabis more accessible to their citizens. This bill also allowed for previously convicted offenders to be resentenced under the terms of the new law.

Legalization 98

Legalization Epilepsy Cannabis Legislation 98

Cannabis Law Report

NOVEMBER 22, 2019

In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition. Source: [link].

Sativa 59

Sativa Medicine Legalization Epilepsy 59

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. But even with the TTOR’s focus on prevention, treatment, and recovery, illicit operations continue to wreak havoc.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Veriheal

JANUARY 15, 2021

So does that mean that there is no access to THC for patients in the country? The Medical Cannabis Access Programme. This legislation outlines the requirements for certain patients to have access to the MCAP. Severe and Treatment-Resistant Refractory Epilepsy. Not exactly. Spasticity Related to Multiple Sclerosis.

Legalization 57

Legalization Therapy Access Legislation 57

Cannabis Law Report

FEBRUARY 19, 2022

Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers. Until 2019, however, no law provided a way to access that oil. total THC to treat intractable seizures or epilepsy in certain circumstances.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

MassRoots

MAY 12, 2020

As a beacon of hope for patients in Georgia, an executive director has finally been appointed by the Access to Medical Cannabis Commission to oversee the next stages of development for the state’s medical marijuana program. A Brief History. For many patients, low-THC oil and CBD isolates simply are not enough to treat debilitating symptoms.

Oil 53

Oil Programs Access Patients 53

Canna Care Docs

SEPTEMBER 18, 2020

Yes, you will be able to upload your records directly to your patient portal which you will receive access to. Governor Terry McAuliffe signed House Bill 1445 and Senate Bill 1235 in March 2015. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

DECEMBER 9, 2019

Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. As CBD becomes increasingly prevalent, accessible and mainstream, it is expected that pet-related CBD products will continue to represent a massive opportunity for brands in the market.

Pets 59

Pets CBD Research and Development Epilepsy 59

Cannabis Law Report

JANUARY 30, 2019

Access the full document at. While this is a positive step and will provide a new treatment option for those with two types of intractable epilepsy, it is my understanding that this scheduling action relates only to CBD in an FDA-approved formulation. Access the full document at. What is the status of this request?

Research and Development 63

Research and Development DEA CBD Law 63

Greencamp

AUGUST 16, 2018

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

OCTOBER 24, 2019

It will allow for regulated, supervised and limited access for our sick citizens especially those with cancer, HIV/ AIDS, glaucoma, and epilepsy. ANGUILLA | Status: Medicinal + Decriminalisation Being Debated. Anguilla has proposed new Cannabis decriminalization laws. Cannabis is illegal in Haiti, and so is any related action.

Law 45

Law Medicine Decriminalization Oil 45

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. Results of the treatment.

Oil 40

Oil Treatment Patients THC 40

Cannabis Law Report

OCTOBER 26, 2019

iv Named-patient and compassionate use proceduresThe TG Act provides mechanisms that allow individuals to gain limited access to UTGs (defined in Section II.iii). The Special Access Scheme (SAS) provides three pathways for access to UTGs: a Category A is a notification pathway that can only be accessed by medical practitioners (i.e.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

SpeedWeed

MAY 22, 2021

Due to it’s high temporal value, EEG shines at detecting epilepsy, sleep disorders, dementia and any other structural brain disease or disorder. Psilocybin and LSD have shown a remarkable potential to help treatment-resistant depression. Carhart-Harris 2015): In 2015, Robin L.

Research and Development 52

Research and Development Microdosing Wellness and Beauty Pets 52

Medical Cannabis Seedbank

AUGUST 6, 2018

Synthesized CBD, and carried out the first study on its effects on epilepsy patients over 30 years ago. The government implemented a program aimed at granting access to medical cannabis and later modified this to allow cannabis cultivation for medical use. He first isolated THC more than 50 years ago. 4) Spain- senior researchers.

Research and Development 61

Research and Development Cultivation Chronic Pain Cannabis 61

Veriheal

MAY 11, 2023

In 2015, Texas passed the Compassionate Use Act, which allowed patients with intractable epilepsy to access low-THC cannabis oil containing no more than 0.5% THC and at least 10% CBD. Stephanie Klick, was introduced during the 2021 legislative session in Texas.

Programs 102

Programs Chronic Pain Conditions THC 102

SpeedWeed

APRIL 29, 2021

The bill was drafted by Representative Stephanie Klick, a Republican and the same person who wrote the initial 2015 medical cannabis bill in Texas. . As of now, only patients with terminal cancer, intractable epilepsy, seizures, multiple sclerosis, spasticity, amyotrophic lateral sclerosis, autism, and other neurodivergent issues are covered.

Programs 52

Programs Chronic Pain Access Patients 52

Veriheal

SEPTEMBER 22, 2021

Contrastingly, in March 2015, a group of Republican military veterans was left feeling disappointed after lawmakers rejected their attempt to legalize medical cannabis. “We’re encouraged that SB711 has been advanced by the Judiciary Committee,” said DeVaughn Ward , who serves as senior legislative counsel for the Marijuana Policy Project.

Legalization 111

Legalization Patients Cultivation Legislation 111

Cannabis Law Report

JANUARY 9, 2019

SB90 would allow doctors to prescribe marijuana as they do any other drug useful for treatment of an illness or for pain management assistance. Meanwhile, HB209 is related to legalization of medical marijuana and the use of homegrown marijuana for medical treatments. Stephanie Klick passed the House on a vote of 108-38.

Treatment 40

Treatment Legislation Patients Epilepsy 40